122 related articles for article (PubMed ID: 6706732)
1. The therapeutic advantage of combined X-rays and melphalan.
Joiner MC; Bremner JC; Denekamp J
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):385-92. PubMed ID: 6706732
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
Lelieveld P; Scoles MA; Brown JM; Kallman RF
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
[TBL] [Abstract][Full Text] [Related]
3. Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
Horsman MR; Brown DM; Lemmon MJ; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1307-10. PubMed ID: 2944859
[TBL] [Abstract][Full Text] [Related]
4. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys.
Rojas A; Denekamp J; Johns H; Kjellen E; Tsang R; Nilsson P; Stratford MR; Dennis MF; Joiner MC
Radiat Res; 1996 Apr; 145(4):419-31. PubMed ID: 8600502
[TBL] [Abstract][Full Text] [Related]
6. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
Brown JM; Lemmon MJ
Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
[TBL] [Abstract][Full Text] [Related]
7. The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin.
Benstead K; Moore JV
Br J Cancer; 1990 Jul; 62(1):48-53. PubMed ID: 2390482
[TBL] [Abstract][Full Text] [Related]
8. Effects of radiomodifiers on high and low LET responses in vivo.
Rojas A; Maughan RL; Denekamp J
Radiother Oncol; 1984 Jun; 2(1):65-73. PubMed ID: 6505278
[TBL] [Abstract][Full Text] [Related]
9. Effect of cancer chemotherapeutic drugs on the radiation-induced skin reactions in mouse feet.
von der Maase H
Br J Radiol; 1984 Aug; 57(680):697-707. PubMed ID: 6466943
[TBL] [Abstract][Full Text] [Related]
10. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
11. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiation response by paclitaxel in mice according to different treatment schedules.
Cividalli A; Arcangeli G; Cruciani G; Livdi E; Cordelli E; Danesi DT
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1163-70. PubMed ID: 9539573
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
Rojas A; Joiner MC; Hodgkiss RJ; Carl U; Kjellen E; Wilson GD
Int J Radiat Oncol Biol Phys; 1992; 23(2):361-6. PubMed ID: 1587757
[TBL] [Abstract][Full Text] [Related]
14. Combined modality treatment with ternary Cu(II) complexes and X rays.
O'Hara JA; Douple EB; Abrams MJ; Giandomenico CM; Bradley FC; McElligott MA; Caruso FS
Int J Radiat Oncol Biol Phys; 1992; 22(3):607-12. PubMed ID: 1735700
[TBL] [Abstract][Full Text] [Related]
15. Effect of peplomycin or camptothecin-11 on X-ray skin injuries of ICR hairless mice.
Kawahara K; Kano E; Ueda K
J Dermatol; 1994 Jul; 21(7):465-73. PubMed ID: 8089365
[TBL] [Abstract][Full Text] [Related]
16. Response of previously irradiated skin to combinations of x radiation, hyperthermia, and cis-diamminedichloroplatinum.
Baker D; Sager H; Constable W; Goodchild N
Cancer Invest; 1984; 2(1):15-9. PubMed ID: 6538454
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
Sheldon PW; Hill SA; Foster JL; Fowler JF
Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic advantage of combined heat and X rays on a mouse fibrosarcoma.
Stewart FA; Denekamp J
Br J Radiol; 1978 Apr; 51(604):307-16. PubMed ID: 647188
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
Hill SA; Fowler JF
Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation.
Bartelink H; Kallman RF; Rapacchietta D; Hart GA
Radiother Oncol; 1986 May; 6(1):61-74. PubMed ID: 3715061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
